Announcement under Regulation 30 (LODR)-Investor Presentation

In continuation to our Letter dated September 12, 2022, please find enclosed herewith the Investor's Presentation which will be made during RPG Annual Investor Conference 2022. Kindly take the same on record.

12 days ago



Sentiments detected

Positive 8
  • Company Financial Performance Profit Margins Consistent Trajectory EBITDA Margin reaches 22.5% & PBT Margin 19.5% EBITDA% 22.5% 20%

  • Key Highlights of Q1 FY 2022-23 Well executed priorities in Domestic Formulations - Faster than market growth - 20.9%* vs 6.6%** 1.

  • Enhance margins 30% PBT growth; despite inflation, geo-political stress - Building iconic brands into strategic assets; expanding Al fl~~

  • Highest ever EBITDA margin at 22.5% Thrust on new PCM (products, customers, markets) in International Formulations Healthy, improving sales parameters Prestigious "CFBP Jamnalal Bajaj Award" recognizing value driven business practices Debt free with healthy net cashflow People initiatives - happiness, capability development * Domestic Formulations internal growth (Q1 FY23)

  • Rating reaffirmation factors: - Strong brands in the Indian Pharmaceutical Industry - Significant improvement in operating performance Improvement in sales hygiene Cost rationalisation since FY20 - Robust capital structure and strong coverage indicators D ecline in the company's debt levels Healthy cash flows No major debt-funded capital expenditure (capex) - Expansion of product portfolio and geographical presence augur well for growth prospects

  • ESG Targets and Initiatives Environment Goals Social Goals Governance Goals Carbon Emission Diversity & Inclusion Data Integrity 33% reduction in FY23 50% increase in gender diversity in Digitalization across Plants

  • FY 2022-23 priorities Sustain growth momentum (top-line, Acquire new customers in IF and API bottom-line, all business segments) (Continue to) grow in chronic and [E specialty in DF (new product, new - Accelerate digital transformation customer segments) ~J ~ (Continue to) build iconic/legacy itt Sustain a happy, performance driven culture; brands into strategic assets augment organization capability lL

  • Further enhance salesforce Step up on sharing the RPG LS transformation productivity underway

Negative 0

    Mentioned Phrases & Organizations

    Important keywords detected (20+)

    presentation (13)
    margin (9)
    rpg (8)
    statements (7)
    growth (7)
    information (7)
    life (6)
    pbt (6)
    investor (5)
    sciences (5)
    document (5)
    new (5)
    product (5)
    formulations (5)
    rpg life (5)
    life sciences (5)
    rpg life sciences (5)
    made (4)
    forward (4)
    looking (4)

    Organizations identified (4+)

    RAJ Es H (1)
    RPG Life Sciences (1)
    Formulations Formulations (1)
    Indian Pharmaceutical Industry (1)

    Features are experimental.